How Big Pharma Avoids Billions in Taxes
Mar 11th 2013 8:00PM
Updated Mar 11th 2013 9:00PM
In the following video, Motley Fool health care bureau chief Brenton Flynn discusses a recent Bloomberg article, which highlights the incredible benefits pharmaceutical companies enjoy through tax management strategies. Brenton tells investors who is profiting and by how much, and why other large-cap health care companies like UnitedHealth Group and Express Scripts are missing out.
One of the biggest beneficiaries of a tax management strategy last year was Abbott Labs. For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, The Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.
The article How Big Pharma Avoids Billions in Taxes originally appeared on Fool.com.Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Express Scripts, Johnson & Johnson, and UnitedHealth Group. The Motley Fool owns shares of Express Scripts and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.